| Misti Dawn Cline, | |
|
1225 E Poplar St, Davisville, WV 26142-9615 | |
| (304) 834-1618 | |
| Not Available |
| Full Name | Misti Dawn Cline |
|---|---|
| Gender | Female |
| Speciality | Licensed Practical Nurse |
| Location | 1225 E Poplar St, Davisville, West Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417276197 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | 27984 (West Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Misti Dawn Cline, 1225 E Poplar St, Davisville, WV 26142-9615 Ph: (304) 834-1618 | Misti Dawn Cline, 1225 E Poplar St, Davisville, WV 26142-9615 Ph: (304) 834-1618 |
News Archive
Abusive head injury, sometimes referred to as shaken baby syndrome or non-accidental trauma, is the third leading cause of head injuries in small children in the US. For children under the age of 1 year, it is the cause of the majority of serious head injuries.
Protica, Inc., the makers of the first protein shot, Profect®, and dozens of the world's most compact protein and energy drinks, has now set its sights on bulk packaging, thanks to International Dispensing Corporation's (IDC) (IDND.PK) patented aseptic tap The Answer™.
Cord Blood America, Inc., the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally, announced today that Biocordcell Argentina S.A. is opening a new franchise headquartered in Campinas, Brazil, a city of more than one million in the state of Sao Paulo.
The study found that children living within 75 meters (about 82 yards) of a major road had an almost 50 percent greater risk of having had asthma symptoms in the past year than were children who lived more than 300 meters (about 328 yards) away.
Affymetrix, Inc. and Lineagen, Inc., an innovative molecular diagnostics company focused on complex, genetically linked disorders, today announced the companies have signed an agreement to incorporate Affymetrix' GeneChip technology into Lineagen's next-generation FirstStepDx, a genetic evaluation service for individuals with developmental delay (DD), intellectual disability (ID), and autism spectrum disorders (ASD).
› Verified 8 days ago